Currently, the most frequently cited diagnostic and prognostic biomarkers for HNSCC are HPV DNA/mRNA, HPV-E6 serotype, HPV ctDNA, EBV RNA, and p16^Ink4a. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.